FDA clears Hologic bone density system

Hologic has received FDA clearance to incorporate the U.S. National Health and Nutrition Examination Survey (NHANES) Whole Body Reference Data into its Discovery dual x-ray absorptiometry (DXA) systems.

These body composition values treat the management of diseases and conditions when the disease or condition itself, or its treatment, can affect the relative amounts of fat and lean tissue.

The FDA clearance of the Hologic Advanced Body Composition Assessment package opens a new market for the Hologic Discovery whole-body DXA systems, which have primarily been used to measure osteoporosis in women after menopause, according to the Bedford, Mass.-based developer of diagnostic products for women.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.